Glycerol trioleate

CAS No. 122-32-7

Glycerol trioleate( Glyceryl trioleate | Oleic triglyceride )

Catalog No. M17889 CAS No. 122-32-7

Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
100MG Get Quote In Stock
200MG 33 In Stock
500MG 60 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Glycerol trioleate
  • Note
    Research use only, not for human use.
  • Brief Description
    Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.
  • Description
    Glyceryl trioleate is a a fat-mimicking material that when mixed with glyceryl trierucate forms Lorenzo's oil. Lorenzo's oil has been used to reduce the saturated VLCFA level in the plasma of X-ALD patients.
  • In Vitro
    RT-PCR Cell Line:Tel‐E6E7 Concentration:20 μM Incubation Time:48 h Result:Reduced the IL-6 expression and ROS generation.
  • In Vivo
    ——
  • Synonyms
    Glyceryl trioleate | Oleic triglyceride
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Others
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    122-32-7
  • Formula Weight
    885.45
  • Molecular Formula
    C57H104O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (112.94 mM)
  • SMILES
    CCCCCCCCC=CCCCCCCCC(=O)OCC(COC(=O)CCCCCCCC=CCCCCCCCC)OC(=O)CCCCCCCC=CCCCCCCCC
  • Chemical Name
    propane-1,2,3-triyl trioleate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • HNPMI

    HNPMI is an EGFR inhibitor that induces G0/G1 phase arrest of CRC cells in colorectal cancer, regulates enzymes associated with apoptosis, and can promote apoptosis, and can be used for the study of colorectal cancer.

  • Bomedemstat ditosyla...

    Bomedemstat ditosylate (IMG-7289 ditosylate) is an orally active lysine-specific demethylase 1 (LSD1) inhibitor with antitumor activity that potentiates the response to PD-1 inhibition in a homozygous model of SCLC, inhibits cancer cell proliferation, and induces apoptosis.

  • Ac-DEVD-CHO

    Ac-DEVD-CHO is a specific Caspase-3 inhibitor (Ki: 230 pM) with inhibitory effects on SLNT-induced apoptosis.